These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23998903)

  • 1. Crystallographic fragment-based drug discovery: use of a brominated fragment library targeting HIV protease.
    Tiefenbrunn T; Forli S; Happer M; Gonzalez A; Tsai Y; Soltis M; Elder JH; Olson AJ; Stout CD
    Chem Biol Drug Des; 2014 Feb; 83(2):141-8. PubMed ID: 23998903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragment-based screen against HIV protease.
    Perryman AL; Zhang Q; Soutter HH; Rosenfeld R; McRee DE; Olson AJ; Elder JE; Stout CD
    Chem Biol Drug Des; 2010 Mar; 75(3):257-68. PubMed ID: 20659109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic, structural mimetics of the β-hairpin flap of HIV-1 protease inhibit enzyme function.
    Chauhan J; Chen SE; Fenstermacher KJ; Naser-Tavakolian A; Reingewertz T; Salmo R; Lee C; Williams E; Raje M; Sundberg E; DeStefano JJ; Freire E; Fletcher S
    Bioorg Med Chem; 2015 Nov; 23(21):7095-109. PubMed ID: 26474665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures.
    Tong L; Pav S; Pargellis C; Dô F; Lamarre D; Anderson PC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8387-91. PubMed ID: 8378311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting dynamic pockets of HIV-1 protease by structure-based computational screening for allosteric inhibitors.
    Kunze J; Todoroff N; Schneider P; Rodrigues T; Geppert T; Reisen F; Schreuder H; Saas J; Hessler G; Baringhaus KH; Schneider G
    J Chem Inf Model; 2014 Mar; 54(3):987-91. PubMed ID: 24528206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment screening and HIV therapeutics.
    Bauman JD; Patel D; Arnold E
    Top Curr Chem; 2012; 317():181-200. PubMed ID: 21972022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Mutations Can Resist Drug Binding yet Keep HIV-1 Protease Functional.
    Appadurai R; Senapati S
    Biochemistry; 2017 Jun; 56(23):2907-2920. PubMed ID: 28505418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling.
    Lee H; Ren J; Pesavento RP; Ojeda I; Rice AJ; Lv H; Kwon Y; Johnson ME
    Bioorg Med Chem; 2019 May; 27(10):1981-1989. PubMed ID: 30940566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flap-site Fragment Restores Back Wild-type Behaviour in Resistant Form of HIV Protease.
    Luchi A; Angelina E; Bogado L; Forli S; Olson A; Peruchena N
    Mol Inform; 2018 Dec; 37(12):e1800053. PubMed ID: 30051611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational analysis of HIV-1 protease protein binding pockets.
    Ko GM; Reddy AS; Kumar S; Bailey BA; Garg R
    J Chem Inf Model; 2010 Oct; 50(10):1759-71. PubMed ID: 20925403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing binders from false positives by free energy calculations: fragment screening against the flap site of HIV protease.
    Deng N; Forli S; He P; Perryman A; Wickstrom L; Vijayan RS; Tiefenbrunn T; Stout D; Gallicchio E; Olson AJ; Levy RM
    J Phys Chem B; 2015 Jan; 119(3):976-88. PubMed ID: 25189630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor.
    Li Y; Zhang Z; Phoo WW; Loh YR; Li R; Yang HY; Jansson AE; Hill J; Keller TH; Nacro K; Luo D; Kang C
    Structure; 2018 Apr; 26(4):555-564.e3. PubMed ID: 29526431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule regulation of protein conformation by binding in the Flap of HIV protease.
    Tiefenbrunn T; Forli S; Baksh MM; Chang MW; Happer M; Lin YC; Perryman AL; Rhee JK; Torbett BE; Olson AJ; Elder JH; Finn MG; Stout CD
    ACS Chem Biol; 2013; 8(6):1223-31. PubMed ID: 23540839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease.
    Chellappan S; Kairys V; Fernandes MX; Schiffer C; Gilson MK
    Proteins; 2007 Aug; 68(2):561-7. PubMed ID: 17474129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into a mutation-assisted lateral drug escape mechanism from the HIV-1 protease active site.
    Sadiq SK; Wan S; Coveney PV
    Biochemistry; 2007 Dec; 46(51):14865-77. PubMed ID: 18052195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3.
    Heaslet H; Lin YC; Tam K; Torbett BE; Elder JH; Stout CD
    Retrovirology; 2007 Jan; 4():1. PubMed ID: 17212810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity.
    Logsdon BC; Vickrey JF; Martin P; Proteasa G; Koepke JI; Terlecky SR; Wawrzak Z; Winters MA; Merigan TC; Kovari LC
    J Virol; 2004 Mar; 78(6):3123-32. PubMed ID: 14990731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of small molecule binding. I. Accurate identification of strong inhibitors in virtual screening.
    Ding B; Wang J; Li N; Wang W
    J Chem Inf Model; 2013 Jan; 53(1):114-22. PubMed ID: 23259763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ninety-nine is not enough: molecular characterization of inhibitor-resistant human immunodeficiency virus type 1 protease mutants with insertions in the flap region.
    Kozísek M; Sasková KG; Rezácová P; Brynda J; van Maarseveen NM; De Jong D; Boucher CA; Kagan RM; Nijhuis M; Konvalinka J
    J Virol; 2008 Jun; 82(12):5869-78. PubMed ID: 18400858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nine crystal structures determine the substrate envelope of the MDR HIV-1 protease.
    Liu Z; Wang Y; Brunzelle J; Kovari IA; Kovari LC
    Protein J; 2011 Mar; 30(3):173-83. PubMed ID: 21394574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.